Pyxis Oncology SEC Filings
NASDAQ: PYXSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
2.03+0.04 (+2.01%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Pyxis Oncology filing overview
This page lists 1 recent SEC filings by Pyxis Oncology (PYXS), including 1 4/A. Form 10-K is the audited annual report, 10-Q the quarterly report, 8-K covers material events, and Form 4 reports insider transactions. All documents link directly to SEC EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
PYXS SEC filings
| Filed | Form | Description | Document |
|---|---|---|---|
| Oct 9, 2026 | 4/A | Statement of changes in beneficial ownership (amendment) | View on EDGAR |